Elan Beats Investor Fraud Claims Over Drug Prospects
A New York federal judge on Tuesday tossed two class actions alleging that Elan Corp. PLC misled investors about the prospects for two of its drugs, one a possible treatment for...To view the full article, register now.
Already a subscriber? Click here to view full article